This collection
is approved on the condition that FDA update form 2767 by revising
the burden statement to comply with the Paperwork Reduction Act of
1995 and by revising the expiration date. OMB notes that FDA
allowed approval of this collection to lapse which is a violation
of the Paperwork Reduction Act. FDA shall take additional steps to
ensure that such lapses do not occur in the future.
Inventory as of this Action
Requested
Previously Approved
11/30/2000
11/30/2000
1,600
0
0
144
0
0
0
0
0
The FDA has the statutory authority
under CFR parts 1020, 1030, 1040, and 1050. The Notice of
Availability of Sample Electronic Product (form FDA 2767) is used
to inform CDRH of the location of sample products which are being
requested for testing to confirm that the products comply with
performance standards.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.